Abstract
BackgroundImmunosupressive therapy, especially tumor necrosis factor-α (TNF-α) inhibitors can induce viral reactivation and potentially fatal liver failure in patients with concurrent Hepatitis B virus (HBV) or Hepatitis C virus (HCV)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have